GNOM Long 6/23/24Looking Higher in wave (iii) of {iii} through at least 12.53 against the wave {ii} low of 9.57.
Key stats
About Global X Genomics & Biotechnology ETF
Expense ratio
0.50%
Home page
Inception date
Apr 5, 2019
GNOM is Global Xs take on biotech, with more of an emphasis on genomics specifically. The fund fleshes out its description of this sector by including companies that derive more than 50% of their revenues from the following five business activities: (i) gene editing, (ii) genomic sequencing, (iii) development and testing of genetic medicine/therapies, (iv) computational genomics and genetic diagnostics, and/or (v) biotechnology. The fund uses a proprietary natural language processing algorithm to identify and rank eligible firms based on public documents, such as filings and disclosures. Holdings may span the market-cap spectrum and come from across the globe, including some emerging markets. The market-cap-weighted index is reconstituted and rebalanced semi-annually.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
GNOM A Good ETF that Captures the Genome & Biotech RevolutionBiotech in my opinion will be the biggest sector of growth in the 21st Century. Lot of value here in this ETF and it has the potential to explode in growth for a long time. Other good ETFs for this sector are ARKG IBB XBI. New highs in the next few years is my call on GNOM
$GNOM Went slightly lower than the double bottom and bounced.Medium bounce here, prbly not expecting much more from this one.
$GNOM A bit of buying at that bottom hammer, watching for popNeeds to break above that trend line, possible double bottom with that last hammer.
$GNOM Bounced from wedge, and failed from top doji.Too much selling after the wedge break, and broke down.
$GNOM Looks ready to bounce here.Tightening wedge along with some buy volume toward the end, looking for a upward push.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.